"Why Choose Belgium? Unleashing the Potential of Life Sciences in Brussels"
Carve Startup Labs
Your Trusted Internationalization Partner for Startup Bridge, Global Expansion and Launchpad Support
In the fast-paced world of life sciences and medical technology, Belgium stands as a beacon of innovation, with the Brussels-Capital Region leading the charge. Renowned for its central location in Europe and robust pharmaceutical research and development (R&D) landscape, Belgium has emerged as one of the global "medicine valleys." This article explores the key facets of Belgium's life sciences sector, highlighting its prowess in pharmaceuticals, MedTech, and the transformative realm of e-health.
Belgium: Central Hub of Europe, Powerhouse in Pharmaceutical Research and Drug Exports, One of 3 “Medicine Valleys” in the World
Belgium, positioned at the heart of Europe, not only serves as the continent's central hub but also commands a prominent role in pharmaceutical research and drug exports. With a focus on robust research capabilities, substantial R&D investments, and unwavering policy support, Belgium proudly claims its spot among the world's top three "medicine valleys." The Brussels Capital Region, home to prestigious academic hospitals such as Brussels UZ, Erasme Hospital, Saint-Luc Hospital, and the Jules Bordet Institute dedicated to cancer research, is at the forefront of pioneering initiatives in rare diseases and new drug development.
"Belgium's Life Sciences Triumph: A €65.5 Billion Powerhouse Leading Global Healthcare Advancements"
The life sciences industry in Belgium is not just thriving; it's a powerhouse. With a staggering €65.5 billion turnover in the pharmaceutical sector, Belgium boasts the highest per capita medical research and development investment in Europe. The Brussels Capital Region, with its strategic focus on continuity of care, patient empowerment, prevention, and personalized medicine, is driving advancements that reverberate globally.
"Brussels: Leading the Charge in Global Oncology Research and Breakthrough Clinical Trials"
Brussels has emerged as a global hub for oncology research, conducting a remarkable 19% of all clinical trials related to cancer worldwide. Notably, pharmaceutical giant Pfizer has chosen Brussels as the location for one of its two global Phase 1 clinical trial units, further solidifying the city's position in cutting-edge cancer research.
"E-Health Revolution in Brussels: A Transformative Wave of Digital Healthcare Innovation"
Brussels is at the forefront of the E-health revolution, with 50% of its residents granting consent for Electronic Medical Records (EMR). All 18 hospitals in the region, along with 9,000 healthcare professionals, have fully embraced EMR technology. This widespread adoption not only highlights Brussels' commitment to digital health but also sets a global standard for seamless healthcare data management.
"Brussels-Capital Region: A Strategic Haven for Pharma and MedTech Innovation with Lucrative Incentives"
The Brussels-Capital Region becomes a magnet for pharmaceutical and MedTech industries, offering enticing research and development incentives. With a maximum effective tax rate of 3.75%, full amortization of intellectual property, and various investment deductions, Brussels provides an ideal environment for fostering innovation. These incentives position the region as a key player in driving scientific advancement, attracting businesses, and shaping the future of the life sciences industry.
MedTech Boom in Brussels: €3.5 Billion Turnover, 20,000 Jobs, and Innovative Start-up Accelerator Programs
领英推荐
Brussels is witnessing a MedTech boom, with a robust €3.5 billion turnover and 20,000 jobs in the industry. The city's commitment to fostering innovation is evident through programs like MedTech Accelerator?, a startup initiative that has supported over 35 projects since 2016. The MedTech Atelier? prototyping service further underscores Brussels' dedication to nurturing groundbreaking advancements in medical technology.
Conclusion:
In the race against time in the life sciences sector, Brussels emerges as a frontrunner, with Belgium positioning itself as a global leader in pharmaceuticals, MedTech, and cutting-edge research. The collaborative efforts of the Brussels-Capital Region, coupled with its strategic initiatives and incentives, make it a nucleus for innovation that transcends geographical boundaries. As the world looks to the future of healthcare, Brussels stands ready to shape the narrative, unlocking the full potential of the life sciences sector and daring to beat the clock in the pursuit of better, more advanced medical solutions for patients, doctors, and researchers alike.
Considering the possibility of expanding your startup presence to Belgium?
Carve Startup Labs invites Indian startups to join our upcoming "Indian Startup Delegation to Belgium #Brussels"! ?????????? Explore the reasons why Belgium stands out as a top choice for expanding your business and accelerating your startup's development.
Seize the moment! Nominate your startup for the Carve Startup Labs Indian Startup delegation to Belgium. Unleash a universe of possibilities and strategically position your venture for unprecedented growth.??????
Secure Your Spot Among the #Top20 Startup from India?
?? Nomination Link: Click here
?? For More Details:Contact us to explore the comprehensive benefits of this delegation and elevate your startup. Reach out for detailed information and secure your spot in this transformative experience.
Contact - [email protected], [email protected]
#Why.Brussels #ScaleUpWithCSL #Belgium #Brussels #ExpandYourStartup #GoGlobal
Article by Alisha Davis